L
Luis M. Ruilope
Researcher at European University of Madrid
Publications - 891
Citations - 109166
Luis M. Ruilope is an academic researcher from European University of Madrid. The author has contributed to research in topics: Blood pressure & Renal function. The author has an hindex of 94, co-authored 841 publications receiving 97778 citations. Previous affiliations of Luis M. Ruilope include Lund University & Mayo Clinic.
Papers
More filters
Journal Article
Chronic kidney disease and global cardiovascular risk in essential hypertension.
TL;DR: Determination of the presence of microalbuminuria and estimation of glomerular filtration rate are mandatory in order to ensure an adequate evaluation of global cardiovascular risk in the hypertensive patient.
Journal ArticleDOI
Blood pressure targets in patients with chronic kidney disease: MDRD and AASK now confirming SPRINT.
TL;DR: A recent analysis of the combined MDRD and AASK cohorts supports previous evidence on nephroprotection but also findings from the SPRINT trial on all-cause mortality benefits of intensive versus usual BP control in individuals with CKD.
Journal ArticleDOI
Treating hypertension with angiotensin II receptor blockers: A step ahead of blood pressure reduction?
Luis M. Ruilope,Massimo Volpe +1 more
TL;DR: The evidence that ARBs can have benefits at any stage of the cardiovascular disease continuum underlies the potential beneficial effects of these agents — independent of blood pressure reduction — in a wide variety of patients at risk of cardiovascular major events.
Journal Article
The effect of nifedipine GITS on outcomes in patients with previous myocardial infarction: A subgroup analysis of the INSIGHT study
Giuseppe Mancia,Luis M. Ruilope,Morris J. Brown,Christopher R. Palmer,Talma Rosenthal,Alain Castaigne,Peter W. De Leuw,Gilbert Wagener +7 more
TL;DR: The results of this subgroup analysis are consistent with INSIGHT's overall findings of no significant differences in efficacy, suggesting that post-MI hypertensive patients are no more likely to suffer further events when treated with long-acting nifedipine than on co-amilozide.
Journal ArticleDOI
New guidelines of the European society of hypertension
Julian Segura,Luis M. Ruilope +1 more
TL;DR: Some aspects of the new guidelines are reviewed: why they were needed, revisions since the previous version, and how their recommendations can help improve blood pressure control are reviewed.